These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 23917187)

  • 1. [Bridge to bridge surgery;conversion from extracorporeal left ventricular assist device to implantable left ventricular assist device].
    Kinoshita O; Ono M
    Kyobu Geka; 2013 Jul; 66(8 Suppl):690-5. PubMed ID: 23917187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center experience of the bridge-to-bridge strategy using the Nipro paracorporeal ventricular assist device.
    Yoshitake S; Kinoshita O; Nawata K; Hoshino Y; Itoda Y; Kimura M; Yamauchi H; Ono M
    J Artif Organs; 2018 Dec; 21(4):405-411. PubMed ID: 29943370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.
    Hanke JS; Rojas SV; Cvitkovic T; Wiegmann B; Horke A; Warnecke G; Haverich A; Schmitto JD
    Interact Cardiovasc Thorac Surg; 2017 Oct; 25(4):503-508. PubMed ID: 28962493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device.
    Yoshioka D; Sakaguchi T; Saito S; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Ueno T; Kuratani T; Sawa Y
    Circ J; 2012; 76(2):372-6. PubMed ID: 22122967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device.
    Kyo S; Minami T; Nishimura T; Gojo S; Ono M
    J Cardiol; 2012 Mar; 59(2):101-9. PubMed ID: 22326458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Scoring System to Predict Ineligibility for Bridge to Implantable Left Ventricular Assist Device as Destination Therapy Before Extracorporeal Ventricular Assist Device Implantation - For the Coming Era of Destination Therapy in Japan.
    Nitta D; Kinugawa K; Imamura T; Endo M; Inaba T; Maki H; Amiya E; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    Circ J; 2016; 80(2):387-94. PubMed ID: 26638871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful management of apical abscess after Nipro left ventricular assisted device explantation by removal of apical cuff and omentopexy.
    Yoshitake S; Itoda Y; Nawata K; Iwase T; Hoshino Y; Kimura M; Kinoshita O; Yamauchi H; Ono M
    J Artif Organs; 2016 Dec; 19(4):396-398. PubMed ID: 27507585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.
    Sakaguchi T; Matsumiya G; Yoshioka D; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Sawa Y
    Circ J; 2013; 77(7):1736-41. PubMed ID: 23595087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heartmate II™ device placement five years following ACORN CorCap™ device implantation.
    Samuels LE; Casanova-Ghosh E; Rodriguez R; Droogan C
    J Card Surg; 2012 Mar; 27(2):264-5. PubMed ID: 22372872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.
    Pagani FD; Aaronson KD; Swaniker F; Bartlett RH
    Ann Thorac Surg; 2001 Mar; 71(3 Suppl):S77-81; discussion S82-5. PubMed ID: 11265871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.